Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2014-02-07
Summary
This is an exploratory study. No formal hypothesis will be tested.
The objectives of this study are to follow Lupus Nephritis patients over a period of 12 months to:
* Establish the baseline biomarker characteristics of patients
* Determine the variability of biomarker measures over time
* Correlate biomarkers with disease phenotype
Conditions
Sponsors & Collaborators
-
Centocor Research & Development, Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Gerald Appel, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Lupus Landmark Study: A Prospective Registry and Biorepository
NCT05934149 ·Status: RECRUITING
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Prediction of Lupus Renal Flares Study
NCT05362812 ·Status: UNKNOWN
-
Functional MRI in Lupus Nephritis
NCT01731054 ·Status: COMPLETED
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
NCT06445127 ·Status: TERMINATED
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
NCT06520670 ·Status: NOT_YET_RECRUITING
-
Disease and Biomarker Profiling of Chinese Lupus Nephritis
NCT06210464 ·Status: NOT_YET_RECRUITING
-
The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis
NCT07130448 ·Status: NOT_YET_RECRUITING
-
Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
NCT04534647 ·Status: UNKNOWN
-
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851 ·Status: UNKNOWN
-
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
NCT06064929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
NCT01273389 ·Status: COMPLETED ·Phase: PHASE2
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
NCT01541670 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
NCT06631404 ·Status: RECRUITING
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?
NCT03664908 ·Status: COMPLETED ·Phase: NA
-
TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis
NCT04218890 ·Status: UNKNOWN
-
The Relation Between Serum Zinc and Lupus Nephritis
NCT06564181 ·Status: NOT_YET_RECRUITING
-
CCCR Lupus Patient Navigator Program
NCT04461158 ·Status: COMPLETED ·Phase: NA